BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020

  Eli Lilly today announced its 2018 financial guidance, including low-single-digit revenue growth driven by volume from recently launched pharmaceutical products.

  December 13, 2017

   · 

  10 min read
• BioForest

  PhaseRx Receives Decision From the Nasdaq Hearings Panel for Continued Listing of Shares

  PhaseRx today announced it received a decision from the Nasdaq Hearings Panel granting PhaseRx’s request for continued listing on The Nasdaq Capital Market until January 31, 2018.

  December 13, 2017

   · 

  5 min read
• Pharm Country

  The Medicines Company to Host Investor Day on January 23, 2018

  The Medicines Company announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City.

  December 13, 2017

   · 

  2 min read
• Business

  Arrakis Therapeutics Announces Exclusive License to RNA-targeted Small Molecule Technology From the University of Pennsylvania

  The license allows utilization of technology related to families of compounds that selectively bind specific nucleic acid structures, called three-way junctions.

  December 13, 2017

   · 

  3 min read
• Business

  Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors

  Dr. Goldberg is a rare disease leader who brings over 20 years of experience developing and commercializing products to address serious unmet medical needs.

  December 13, 2017

   · 

  4 min read
• Biotech Beach

  ReShape Lifesciences Announces Stocking Order From Medical Supplier in Dubai

  This order, the second since Al Zawhari’s initial stocking order in August 2017, is to support increased demand for the Reshape Integrated Dual Balloon System from a leading hospital customer’s growing bariatric program in Dubai.

  December 13, 2017

   · 

  4 min read
• OBIO CAAP Companies Raise More Than $109 Million in Investments

  OBIO CAAP is generously supported by the Federal Government and the Government of Ontario.

  December 13, 2017

   · 

  3 min read
• BioMidwest

  Myonexus Therapeutics Secures $2.5M Seed Financing to Clinically Advance Limb-Girdle Muscular Dystrophy (LGMD) Gene Therapies

  The seed financing will enable Myonexus to initiate a systemic Phase 1/2a clinical trial of MYO-101, the company’s gene therapy candidate for treating LGMD2E (beta-sarcoglycanopathy), in early 2018.

  December 13, 2017

   · 

  5 min read
• Deals

  Millar Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences

  The transition of this product line from Millar will be complete by Dec. 31, 2017

  December 13, 2017

   · 

  2 min read
• Business

  New Quartesian Agreement With Medidata Expands Sponsor Access to the Medidata Clinical Cloud During Clinical Trials

  Quartesian has been a Medidata partner since 2014, with the collaboration facilitating clinical trial breakthroughs for all market segments, from small phase I to large phase III studies.

  December 13, 2017

   · 

  4 min read